Latest filing published 26 Apr 2024 for 众生药业, €82k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -26.6%Entry CN¥15.24 · Close at T+365 CN¥11.19
- -24.9%Entry CN¥14.90 · Close at T+365 CN¥11.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
陈永红: trading record in brief
陈永红 (chief executive) discloses dealings in 众生药业 to SSE / SZSE (CSRC). Between 25 April 2024 and 26 April 2024, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €150k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 26 April 2024 with an open-market purchase (€82k) in 众生药业. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 陈永红
Open company profiles for insider transactions, fundamentals and analyst consensus when available.